| abstract |
A method for screening for cancer, a cancer test, a screening system a patient monitoring system and medicinal dosage form for measuring stimulating a specific, detectable response from a stimulus-responsive neoplasm, comprising administering a neoplasm-affecting treatment, in sufficient quantity to stimulate the response; and drawing a blood sample at a time after administration sufficient to distinguish the response. Administering a GnRH analog to a woman prior to measuring circulating serum tumor markers for ovarian epithelial carcinoma provides an improved screening result. |